))
Why Dr. Rakesh N. Veedu specialises in oligonucleotide therapeutics and how he started SynGenis in response to the pandemic
Manage episode 340849246 series 3263602
Contenu fourni par The Perth Business Podcast. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par The Perth Business Podcast ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
In this episode, we had the pleasure of speaking with Dr Rakesh N. Veedu on the topic of oligonucleotide therapeutics. If you're drawing a blank, we bet you've heard of the scientific pursuits into finding cures for HIV infection, macular degeneration, and spinal muscular atrophy.
What about the endeavour to protect humanity against Covid?
That one's pretty fresh and don't worry, we don't have divisive discussion around whether or not the vaccine is effective in the context of the current climate. We simply talk facts and get into the nitty gritty of how scientists manufacture DNA and RNA in order to diagnose and treat conditions beyond our comprehension.
It's fascinating and I hope you'll join me in the conversation with DR Rakesh. Drop your notes on your preferred channels or find us on social media or via email at theperthbusinesspodcast@gmail.com.
94 episodes
Partager
